Validations: Nitrosamine Risk Assessment & Control Strategy

Interim vs Final Limits: Communicating Changes

Interim vs Final Limits: Communicating Changes Interim vs Final Limits: Communicating Changes The effective management of nitrosamine impurities in pharmaceutical products has become a significant focus for regulatory bodies, particularly concerning the limits for nitrosamines such as N-Nitrosodimethylamine (NDMA). With guidelines evolving under ICH M7 and increasing scrutiny from agencies like the FDA and EMA, pharmaceutical organizations must understand how…

Continue Reading Interim vs Final Limits: Communicating Changes

Carryover and Memory Effects: Preventing False Positives

Carryover and Memory Effects: Preventing False Positives The pharmaceutical industry is under increasing scrutiny to ensure that products are free from contaminants, particularly nitrosamines. Nitrosamine risk assessment, including the implications of carryover and memory effects, is crucial for compliance with regulatory expectations such as those from the US FDA, EMA, and MHRA. This comprehensive guide outlines the steps for mitigating…

Continue Reading Carryover and Memory Effects: Preventing False Positives

Confirmation by MRM Ratio/Retention: Evidence That Convinces

Confirmation by MRM Ratio/Retention: Evidence That Convinces Confirmation by MRM Ratio/Retention: Evidence That Convinces Understanding Nitrosamine Risk Assessment and Its Importance Nitrosamines have garnered significant attention within the pharmaceutical industry due to their potential carcinogenic properties. Nitrosamine impurities, particularly N-nitrosodimethylamine (NDMA), have raised regulatory flags, resulting in stringent guidelines from authorities like the US FDA and the European Medicines Agency…

Continue Reading Confirmation by MRM Ratio/Retention: Evidence That Convinces

Headspace GC-MS for Volatile Nitrosamines: Parameters That Matter

Headspace GC-MS for Volatile Nitrosamines: Parameters That Matter The presence of volatile nitrosamines in pharmaceutical products has become a critical concern given their potential carcinogenic properties. Regulatory bodies, such as the FDA, EMA, and MHRA, have established stringent guidelines for assessing these impurities. This tutorial aims to guide adept professionals through the essential parameters of utilizing headspace gas chromatography-mass spectrometry…

Continue Reading Headspace GC-MS for Volatile Nitrosamines: Parameters That Matter

LC-MS/MS for Semi-Volatiles: Column, Mobile Phase, and Source

LC-MS/MS for Semi-Volatiles: Column, Mobile Phase, and Source In the realm of pharmaceutical analysis, the identification and quantification of semi-volatile organic compounds, particularly nitrosamines, have taken center stage due to their potential risks and regulatory scrutiny. This comprehensive tutorial will guide professionals through the essential components of utilizing LC-MS/MS (Liquid Chromatography with Tandem Mass Spectrometry) for detecting nitrosamines in pharmaceutical…

Continue Reading LC-MS/MS for Semi-Volatiles: Column, Mobile Phase, and Source

Cross-Validation Across Labs/Sites: Equivalence and Transfers

Cross-Validation Across Labs/Sites: Equivalence and Transfers Cross-Validation Across Labs/Sites: Equivalence and Transfers Introduction to Cross-Validation in Pharmaceutical Testing In the pharmaceutical industry, ensuring the integrity and accuracy of analytical data is critical for compliance with regulatory standards and for patient safety. Cross-validation across laboratories and sites is an essential step in the process of analytical method validation, particularly concerning nitrosamine…

Continue Reading Cross-Validation Across Labs/Sites: Equivalence and Transfers

Matrix Effects: Ion Suppression and Confirmation Criteria

Matrix Effects: Ion Suppression and Confirmation Criteria Matrix Effects: Ion Suppression and Confirmation Criteria The pharmaceutical industry faces continual scrutiny regarding the presence of nitrosamines and other potential impurities in drug products. As part of the nitrosamine risk assessment and control strategy, understanding the implications of matrix effects, specifically ion suppression, is crucial for maintaining analytical integrity. This comprehensive guide…

Continue Reading Matrix Effects: Ion Suppression and Confirmation Criteria

Screening vs Confirmatory Methods: Tiered Approaches

Screening vs Confirmatory Methods: Tiered Approaches In the evolving landscape of pharmaceutical quality assurance and control, the management of nitrosamine risks has become a key regulatory focus. This article provides a comprehensive, step-by-step guide on the tiered approaches to analytical methods for nitrosamine risk assessment, aimed at ensuring compliance with regulatory expectations from authorities such as the FDA, EMA, and…

Continue Reading Screening vs Confirmatory Methods: Tiered Approaches

Specificity and Interference: Separating NDSRIs

Specificity and Interference: Separating NDSRIs In the field of pharmaceutical development and regulatory compliance, the focus on nitrosamines has intensified due to their potential carcinogenic effects. The identification and quantitative measurement of N-Nitrosamine Drug Substances Related Impurities (NDSRIs) such as N-Nitrosodimethylamine (NDMA) is critical to ensuring product safety and efficacy. This tutorial provides a comprehensive step-by-step guide to separating NDSRIs,…

Continue Reading Specificity and Interference: Separating NDSRIs

Calibration Curves & LOQ: Linear vs Weighted Fits

Calibration Curves & LOQ: Linear vs Weighted Fits Calibration Curves & LOQ: Linear vs Weighted Fits Introduction to Calibration Curves in Analytical Methods Calibration curves are foundational components in analytical and bioanalytical chemistry, crucial for quantifying the concentration of analytes in a variety of sample matrices. In pharmaceutical applications, particularly within the context of nitrosamine risk assessment, calibration curves inform…

Continue Reading Calibration Curves & LOQ: Linear vs Weighted Fits